Safety and Efficacy of HarmonyTM Transcatheter Pulmonary Valve Implantation ― Clinical and Hemodynamic…

Abstract

BACKGROUND: transcatheter pulmonary valve implantation (TPVI) was developed to treat pulmonary regurgitation (PR) in patients with an enlarged native right ventricular outflow tract. Favorable outcomes have been reported in cohorts from the USA, but data from other regions are limited. METHODS AND RESULTS: (P<0.05). During a median follow-up of 17 months, all patients remained free from reintervention. CONCLUSIONS: TPVI achieved high procedural success and rapid right ventricular reverse remodeling, indicating it is a safe and effective treatment option.

Left Anterior Descending Coronary Artery Compression After Harmony Transcatheter Pulmonary Valve Implantation
Ka-Chun Un, Chun-Ka Wong, Tomohito Kogure +1
Journal of the Society for Cardiovascular Angiography & Interventions10 Sep 2026Peer-reviewedCC BY-NC-ND 4.0Full textEpidemiology & public healthPMCEurope PMC
Early Outcomes of Harmony Transcatheter Pulmonary Valve Implantation in the Middle East: A Single-Center Experience From Saudi Arabia.
Abdullghany M Dowaikh, Amr A Arafat, Sameh F Ahmed +4
CJC pediatric and congenital heart disease14 May 2026Peer-reviewedCC BY-NC-NDFull textEpidemiology & public healthEurope PMCPMC
Multicenter experience of hybrid transcatheter pulmonary valve implantation in patients with a large right ventricular outflow tract
Jun Dong, Junwu Su, Aijun Liu +11
Frontiers in Cardiovascular Medicine20 Oct 2026Peer-reviewedCC BY 4.0Full textEpidemiology & public healthCrossrefEurope PMCPMC
Modified balloon-assisted shoehorn technique for transcatheter aortic valve implantation in functionally horizontal anatomy: a case report
European heart journal. Case reports21 Aug 2026Peer-reviewedCC BYFull textCardiovascular medicineEurope PMC
Gut microbiome-derived metabolic remodeling and the butyrate-IL-18 inflammatory axis after transcatheter aortic valve implantation
C. Chong-Nguyen, C. Ferro, B. Yilmaz +7
medRxiv30 Aug 2026PreprintAll rights reservedFull textCardiovascular medicinemedRxiv

Cite

BibTeX RIS

BibTeX

@article{kogure2026safety,
  title = {{Safety and Efficacy of HarmonyTM Transcatheter Pulmonary Valve Implantation ― Clinical and Hemodynamic Assessment in a Single-Center Japanese Cohort ―}},
  author = {Tomohito Kogure and Daigo Yagishita and Takanori Kawamoto and Arisa Nokubo and Masafumi Yoshikawa and Eiji Shibahashi and Hisao Otsuki and Satoru Domoto and Seiji Asagai and Kei Inai and Takeshi Shinkawa and Hiroshi Niinami and Junichi Yamaguchi},
  journal = {Circulation Journal},
  year = {2026},
  month = aug,
  doi = {10.1253/circj.cj-25-0935},
  url = {https://www.jstage.jst.go.jp/article/circj/90/9/90_CJ-25-0935/_article},
  note = {CC BY-NC-ND},
}

RIS

TY  - JOUR
TI  - Safety and Efficacy of HarmonyTM Transcatheter Pulmonary Valve Implantation ― Clinical and Hemodynamic Assessment in a Single-Center Japanese Cohort ―
AU  - Tomohito Kogure
AU  - Daigo Yagishita
AU  - Takanori Kawamoto
AU  - Arisa Nokubo
AU  - Masafumi Yoshikawa
AU  - Eiji Shibahashi
AU  - Hisao Otsuki
AU  - Satoru Domoto
AU  - Seiji Asagai
AU  - Kei Inai
AU  - Takeshi Shinkawa
AU  - Hiroshi Niinami
AU  - Junichi Yamaguchi
PY  - 2026
DA  - 2026/08/25
JO  - Circulation Journal
DO  - 10.1253/circj.cj-25-0935
UR  - https://www.jstage.jst.go.jp/article/circj/90/9/90_CJ-25-0935/_article
AB  - BACKGROUND: transcatheter pulmonary valve implantation (TPVI) was developed to treat pulmonary regurgitation (PR) in patients with an enlarged native right ventricular outflow tract. Favorable outcomes have been reported in cohorts from the USA, but data from other regions are limited. METHODS AND RESULTS: (P<0.05). During a median follow-up of 17 months, all patients remained free from reintervention. CONCLUSIONS: TPVI achieved high procedural success and rapid right ventricular reverse remodeling, indicating it is a safe and effective treatment option.
SN  - 1347-4820
SN  - 1346-9843
ER  -

Abstract

Related

Cite